| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.ADDR.2008.12.016 |
| P698 | PubMed publication ID | 19394373 |
| P50 | author | Fabienne Rolling | Q33109869 |
| P2093 | author name string | Fabienne Rolling | |
| Philippe Moullier | |||
| Caroline Le Guiner | |||
| Knut Stieger | |||
| Brahim Belbellaa | |||
| P2860 | cites work | Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector | Q46385266 |
| Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial | Q46529042 | ||
| Genomic structure and chromosomal location of the rat gene encoding the zinc finger transcription factor Kid-1. | Q48084190 | ||
| Subantimicrobial dose doxycycline: a unique treatment for rosacea. | Q53855668 | ||
| The use and safety of doxycycline hyclate and other second-generation tetracyclines. | Q55050505 | ||
| Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer | Q59652097 | ||
| Regulation of human factor IX expression using doxycycline-inducible gene expression system | Q73906998 | ||
| Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector | Q77145715 | ||
| Regulation of rod phototransduction machinery by ciliary neurotrophic factor | Q79455997 | ||
| Highly efficient regulation of gene expression by tetracycline in a replication-defective herpes simplex viral vector | Q83017114 | ||
| Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. | Q44213139 | ||
| Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo | Q44223354 | ||
| Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles | Q44260026 | ||
| Tetracycline-inducible transgene expression mediated by a single AAV vector. | Q44276810 | ||
| Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. | Q44287937 | ||
| Improved ecdysone receptor-based inducible gene regulation system | Q44358693 | ||
| Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector | Q44471852 | ||
| Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle | Q44474527 | ||
| A tetracycline-regulated adenoviral expression system for in vivo delivery of transgenes to lung and liver | Q44490527 | ||
| Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect | Q44567174 | ||
| A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain | Q44672776 | ||
| Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. | Q44678036 | ||
| Regulated, electroporation-mediated delivery of pro-opiomelanocortin gene suppresses chronic constriction injury-induced neuropathic pain in rats | Q44872856 | ||
| HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. | Q45007194 | ||
| Inducible silencing of KILLER/DR5 in vivo promotes bioluminescent colon tumor xenograft growth and confers resistance to chemotherapeutic agent 5-fluorouracil | Q45064015 | ||
| Tetracycline-inducible viral interleukin-10 intraocular gene transfer, using adeno-associated virus in experimental autoimmune uveoretinitis. | Q45423992 | ||
| Long-term inducible gene expression in the eye via adeno-associated virus gene transfer in nonhuman primates. | Q45500358 | ||
| Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle | Q45668619 | ||
| Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis | Q45731652 | ||
| Inducible long-term gene expression in brain with adeno-associated virus gene transfer | Q45751214 | ||
| Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors | Q45855564 | ||
| Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases. | Q45871728 | ||
| Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression | Q45873420 | ||
| Intrathecal coelectrotransfer of a tetracycline-inducible, three-plasmid-based system to achieve tightly regulated antinociceptive gene therapy for mononeuropathic rats | Q45873486 | ||
| Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle | Q45875418 | ||
| Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. | Q45877621 | ||
| Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts | Q45880895 | ||
| Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system | Q45887839 | ||
| Transient growth factor delivery sustains regenerated axons after spinal cord injury. | Q45942523 | ||
| KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Krüppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing. | Q22010040 | ||
| The evolutionarily conserved Krüppel-associated box domain defines a subfamily of eukaryotic multifingered proteins | Q24303815 | ||
| Krüppel-associated boxes are potent transcriptional repression domains | Q24563259 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD | Q24602561 | ||
| Tetracycline-reversible silencing of eukaryotic promoters | Q24652702 | ||
| The KAP1 corepressor functions to coordinate the assembly of de novo HP1-demarcated microenvironments of heterochromatin required for KRAB zinc finger protein-mediated transcriptional repression | Q24672128 | ||
| Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity | Q24676926 | ||
| SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins | Q24685694 | ||
| Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter | Q24791061 | ||
| KRAB-containing zinc-finger repressor proteins | Q24792646 | ||
| Manipulation of gene expression by an ecdysone-inducible gene switch in tumor xenografts | Q24797386 | ||
| Regulated and Liver-Specific Tamarin Alpha Interferon Gene Delivery by a Helper-Dependent Adenoviral Vector | Q27469612 | ||
| Conformational changes of the Tet repressor induced by tetracycline trapping | Q27759416 | ||
| Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines | Q28249905 | ||
| Transcriptional activation by tetracyclines in mammalian cells | Q28303934 | ||
| Adeno-associated virus-mediated ILK gene silencing in the rat NAc core | Q28582166 | ||
| The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor | Q31168538 | ||
| Tetracycline-regulated cardiac gene expression in vivo. | Q34141635 | ||
| Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses. | Q34233124 | ||
| Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brain | Q34233867 | ||
| Ocular immune privilege: therapeutic opportunities from an experiment of nature | Q34282825 | ||
| A humanized system for pharmacologic control of gene expression | Q34394730 | ||
| Antibiotic options for treating community-acquired MRSA. | Q34593646 | ||
| Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons | Q42478941 | ||
| Gene transfer into individual muscle fibers and conditional gene expression in living animals | Q42493465 | ||
| Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression. | Q42506402 | ||
| Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators | Q42516387 | ||
| Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain | Q42518623 | ||
| Long-term doxycycline-regulated secretion of erythropoietin by encapsulated myoblasts | Q42524485 | ||
| Long-term and tight control of gene expression in mouse skeletal muscle by a new hybrid human transcription factor | Q42527432 | ||
| Control of erythropoietin secretion by doxycycline or mifepristone in mice bearing polymer-encapsulated engineered cells | Q42818978 | ||
| Inducible nonviral gene expression in the treatment of osteochondral defects. | Q42826214 | ||
| Regulation of gene expression in vivo following transduction by two separate rAAV vectors | Q42827352 | ||
| Targeting of Krüppel-associated box-containing zinc finger proteins to centromeric heterochromatin. Implication for the gene silencing mechanisms. | Q42830538 | ||
| Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells | Q42832998 | ||
| Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. | Q43727676 | ||
| Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors | Q43867096 | ||
| A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo. | Q44052698 | ||
| Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. | Q44088681 | ||
| Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression | Q44134995 | ||
| Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors | Q44138037 | ||
| Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. | Q44178358 | ||
| Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells. | Q35118919 | ||
| Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference | Q35182317 | ||
| The Krüppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. | Q35238471 | ||
| Gene therapy progress and prospects: transcription regulatory systems. | Q35676294 | ||
| Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. | Q35734505 | ||
| Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. | Q35778832 | ||
| Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro | Q35870480 | ||
| Regulatable gene expression systems for gene therapy | Q36569912 | ||
| Molecular targets for retinal vascular diseases | Q36667825 | ||
| Update on rosacea and anti-inflammatory-dose doxycycline | Q36742072 | ||
| Immune responses to gene product of inducible promoters | Q36990105 | ||
| Antimalarial drugs in pregnancy: a review. | Q37239309 | ||
| Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain | Q37245006 | ||
| In vitro- and in vivo-induced transgene expression in human embryonic stem cells and derivatives | Q37254949 | ||
| Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice | Q37303897 | ||
| Krüppel-associated box-mediated repression of RNA polymerase II promoters is influenced by the arrangement of basal promoter elements | Q37727809 | ||
| A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells | Q38313873 | ||
| Tumor inhibition by genomically integrated inducible RNAi-cassettes | Q39114217 | ||
| Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus | Q39685864 | ||
| Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential | Q39720663 | ||
| Conditional repression of the E2 transcription unit in E1-E3-deleted adenovirus vectors is correlated with a strong reduction in viral DNA replication and late gene expression in vitro | Q39879201 | ||
| Tightly regulated gene expression in human hematopoietic stem cells after transduction with helper-dependent Ad5/35 vectors | Q39994382 | ||
| Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. | Q40183219 | ||
| Inducible shRNA expression for application in a prostate cancer mouse model | Q40240530 | ||
| Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat. | Q40262080 | ||
| A versatile tool for conditional gene expression and knockdown | Q40325913 | ||
| Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector | Q40353580 | ||
| Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On | Q40383542 | ||
| Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector | Q40430854 | ||
| New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo. | Q40468763 | ||
| Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. | Q40472175 | ||
| Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector | Q40483556 | ||
| 4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models | Q40513287 | ||
| Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. | Q40532718 | ||
| Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness | Q40537918 | ||
| Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. | Q40554074 | ||
| Tn10 tet operator mutations affecting Tet repressor recognition | Q40561844 | ||
| Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On | Q40573836 | ||
| Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors | Q40657761 | ||
| Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system | Q40688940 | ||
| Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector | Q40741282 | ||
| Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector | Q40753328 | ||
| Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials | Q40790899 | ||
| Recombinant AAV-mediated delivery of a tet-inducible reporter gene to the rat retina | Q40805811 | ||
| Exogenously regulated stem cell-mediated gene therapy for bone regeneration. | Q40810215 | ||
| A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications | Q40823590 | ||
| Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances | Q40846822 | ||
| Lentiviral vectors: regulated gene expression | Q40863126 | ||
| Transiently transfected and stably integrated HIV-1 LTR responds differentially to the silencing activity of the Krüppel-associated box (KRAB) transcriptional repressor domain | Q40935372 | ||
| Construction of an rtTA2(s)-m2/tts(kid)-based transcription regulatory switch that displays no basal activity, good inducibility, and high responsiveness to doxycycline in mice and non-human primates | Q42437364 | ||
| Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions | Q42447004 | ||
| A variety of RNA polymerases II and III-dependent promoter classes is repressed by factors containing the Krüppel-associated/finger preceding box of zinc finger proteins. | Q42474318 | ||
| P433 | issue | 7-8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tetracycline | Q193045 |
| P304 | page(s) | 527-541 | |
| P577 | publication date | 2009-04-23 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | In vivo gene regulation using tetracycline-regulatable systems | |
| P478 | volume | 61 |
| Q34994534 | "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair |
| Q36789161 | A Tet-on and Cre-loxP Based Genetic Engineering System for Convenient Recycling of Selection Markers in Penicillium oxalicum. |
| Q39666140 | A neuroregenerative human ensheathing glia cell line with conditional rapid growth. |
| Q39168641 | A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis |
| Q38075068 | A next step in adeno-associated virus-mediated gene therapy for neurological diseases: regulation and targeting. |
| Q35091890 | A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression. |
| Q37065552 | Adeno-associated Virus-mediated, Mifepristone-regulated Transgene Expression in the Brain |
| Q45870616 | An Engineered Optogenetic Switch for Spatiotemporal Control of Gene Expression, Cell Differentiation, and Tissue Morphogenesis |
| Q39037052 | Antibiotic-dependent expression of early transcription factor subunits leads to stringent control of vaccinia virus replication |
| Q38348602 | CRISPR genome engineering and viral gene delivery: a case of mutual attraction |
| Q35582092 | Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease |
| Q34430996 | Destabilizing domains mediate reversible transgene expression in the brain |
| Q42227411 | Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve |
| Q58614180 | Development of Inducible CD19-CAR T Cells with a Tet-On System for Controlled Activity and Enhanced Clinical Safety |
| Q35086111 | Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer |
| Q34358914 | Dually inducible TetON systems for tissue-specific conditional gene expression in zebrafish. |
| Q33574124 | Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair |
| Q47565577 | Extragonadal Actions of FSH: A Critical Need for Novel Genetic Models |
| Q35220957 | Functional analysis of Drosophila HSP70 promoter with different HSE numbers in human cells |
| Q36983203 | Gene therapy for misfolding protein diseases of the central nervous system |
| Q37942753 | Gene therapy for retinal ganglion cell neuroprotection in glaucoma |
| Q36698991 | Gene transfer for congestive heart failure: update 2013. |
| Q37999164 | Guiding differentiation of stem cells in vivo by tetracycline-controlled expression of key transcription factors. |
| Q34350680 | HSP70 promoter-driven activation of gene expression for immunotherapy using gold nanorods and near infrared light |
| Q56776244 | Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury |
| Q37714960 | Inducible and conditional transgenic mouse models of schizophrenia |
| Q41958907 | Magnetic field-controlled gene expression in encapsulated cells |
| Q37968206 | Modeling human neurodegenerative diseases in transgenic systems |
| Q35380680 | Monitoring the spatiotemporal activities of miRNAs in small animal models using molecular imaging modalities |
| Q37931558 | Nerve surgery and gene therapy: a neurobiological and clinical perspective. |
| Q35915292 | Over-expression of uPA increases risk of liver injury in pAAV-HBV transfected mice |
| Q33664375 | Positive radionuclide imaging of miRNA expression using RILES and the human sodium iodide symporter as reporter gene is feasible and supports a protective role of miRNA-23a in response to muscular atrophy |
| Q39442049 | Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element |
| Q34358693 | Promoter strength driving TetR determines the regulatory properties of Tet-controlled expression systems |
| Q45882136 | Providing sustained transgene induction through affinity-based drug delivery |
| Q37271181 | RILES, a novel method for temporal analysis of the in vivo regulation of miRNA expression. |
| Q33603328 | Recombinant Adeno-Associated Virus-Mediated microRNA Delivery into the Postnatal Mouse Brain Reveals a Role for miR-134 in Dendritogenesis in Vivo |
| Q30495021 | Regulation of retinal function but nonrescue of vision in RPE65-deficient dogs treated with doxycycline-regulatable AAV vectors |
| Q37798450 | Skeletal muscle cells: from local inflammatory response to active immunity. |
| Q47138259 | Tet-On lentiviral transductants lose inducibility when silenced for extended intervals in mammary epithelial cells |
| Q37721932 | The hunt for gene dopers. |
| Q39502530 | Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. |
| Q34063696 | Total Synthesis and Biological Studies of TMC-205 and Analogues as Anticancer Agents and Activators of SV40 Promoter |
| Q97537466 | Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing |
| Q37868574 | Translating promising preclinical neuroprotective therapies to human stroke trials |
| Q37615161 | Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). |
| Q27338028 | Validation of the tetracycline regulatable gene expression system for the study of the pathogenesis of infectious disease |
| Q52431094 | Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system. |
Search more.